Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 319 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Respiratory Illness Clear all

Conditions: Respiratory Tract Infection Acute, Transcriptome, Virus Disease, Bacterial Infections
Interventions: Host Gene Expression; Diagnostic Test
Lead sponsor: Duke University; Other
Eligibility: 2 Years and older
Enrollment: 783 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 10
States / cities: Davis, California • Boston, Massachusetts • Newton, Massachusetts + 7 more

Conditions: Sepsis, Acute Lung Injury(ALI)
Interventions: Not listed
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Upper Respiratory Tract Infection, COVID-19, Flu, Flu Like Illness, Cold
Interventions: Elderberry, Placebo; Dietary Supplement · Other
Lead sponsor: Nutraceuticals Research Institute; Other
Eligibility: 20 Years to 65 Years
Enrollment: 420 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: HIV Infections
Interventions: Lamivudine/Zidovudine, Nelfinavir mesylate, Efavirenz, Lamivudine, Zidovudine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 9
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 6 more

Conditions: Influenza Prevention, Seasonal Influenza
Interventions: VRC-FLUMOS0116-00-VP, ALFQ; Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: COVID-19
Interventions: Convalescent plasma; Biological
Lead sponsor: Hamilton Health Sciences Corporation; Other
Eligibility: 16 Years and older
Enrollment: 940 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Brooklyn, New York • New York, New York

Conditions: Acute Mountain Sickness
Interventions: Budesonide, Acetazolamide, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Bishop, California

Conditions: Gastrointestinal Injury, Acute Mountain Sickness
Interventions: FP, Placebo, High altitude, Sea level; Dietary Supplement · Other
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 17 Years to 39 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Natick, Massachusetts

Conditions: Intubation, Critically Ill
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Recurrent Wheezing, Wheezing Lower Respiratory Illness
Interventions: OM-85, Placebo; Drug
Lead sponsor: OM Pharma SA; Industry
Eligibility: 6 Months to 72 Months
Enrollment: 296 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 31
States / cities: Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 25 more

Conditions: Acute Mountain Sickness and Fatigue
Interventions: Aminophylline 400 mg, Ambrisentan 5 mg, Placebo; Drug · Other
Lead sponsor: Robert J Noveck, M.D.; Other
Eligibility: 18 Years to 50 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Durham, North Carolina

Conditions: Venous Thromboembolism
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Enoxaparin, Rivaroxaban placebo, Enoxaparin placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 40 Years and older
Enrollment: 8,101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 121
States / cities: Birmingham, Alabama • Dothan, Alabama • Geneva, Alabama + 107 more

Conditions: Pneumonia, Sinusitis, Bronchitis, Respiratory Disease, Respiratory Tract Infections
Interventions: Lymphatic Pump Osteopathic Manipulative Therapy; Procedure
Lead sponsor: Geisinger Clinic; Other
Eligibility: 65 Years to 100 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bloomsburg, Pennsylvania

Conditions: Intubation, Intratracheal, Critical Illness, Mechanical Ventilation Complication, Complication of Ventilation Therapy
Interventions: laryngoscopy; Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 365 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Respiratory Infections, Gastrointestinal Diseases
Interventions: Alcohol-based hand sanitizer & quaternary ammonium wipes; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 285 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sepsis, Burn Injury, Wound Healing, Critical Illness, Multiple Organ Dysfunction Syndrome
Interventions: Observational Cohort (No Intervention); Other
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Tampa, Florida • Atlanta, Georgia • Houston, Texas

Conditions: Cancer, Severe Major Depression, Schizophrenia, Bipolar Disorder, Lung Cancer, Breast Cancer, Head and Neck Cancer, Gastrointestinal Cancer, Genitourinary Cancer
Interventions: Virtual Cancer and Mental Health Tumor Board; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Danvers, Massachusetts

Conditions: Bronchopulmonary Dysplasia (BPD), Premature Births, Critical Illness
Interventions: montelukast 4 mg granule, Placebo; Drug
Lead sponsor: Duke University; Other
Eligibility: 7 Days to 28 Days
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Little Rock, Arkansas • Amherst, Massachusetts • Las Vegas, Nevada + 2 more

Conditions: Continuous Positive Airway Pressure, High Altitude Pulmonary Edema
Interventions: CPAP mask system, Nifedipine 30 MG, CPAP mask system without PEEP; Device · Drug
Lead sponsor: CommonSpirit Health; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Breckenridge, Colorado

Conditions: Sepsis, Critical Illness, Respiratory Failure, Nutrition Disorders, Calorie Deficiency, Diaphragm Injury, Quadriceps Muscle Atrophy
Interventions: Caloric delivery will target results of IC measurement.; Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Seriously Ill Patients, Cancer, Heart Failure, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, End-stage Renal Disease, End-stage Liver Disease, Dementia
Interventions: Clinician Implementation Strategy Stage 1: low intensity clinician training, Clinician Implementation Strategy Stage 2: high intensity clinician training, Low patient engagement, High patient engagement; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 2,859 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Palo Alto, California • West Los Angeles, California • Aurora, Colorado

Conditions: Critical Illness, Hypoxia, Brain
Interventions: Music therapy; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 2 Months to 17 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Dementia, Chronic Disease, Neoplasm Metastasis, Lung Neoplasm, Pulmonary Disease, Chronic Obstructive, Heart Failure，Congestive, Liver Cirrhosis, Kidney Failure, Chronic, Lung Diseases, Interstitial, Peripheral Vascular Disease, Diabetes With End Organ Injury
Interventions: EHR-based Clinician Jumpstart; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 2,512 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Seattle, Washington

Conditions: COVID-19
Interventions: PF-07321332, Ritonavir, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 2,091 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 73
States / cities: Pelham, Alabama • Mesa, Arizona • Tucson, Arizona + 46 more

Search by objective public record fields.

A Rapid Test for Acute Respiratory Illness

Recovery of Physical Function After Critical Illness In Older Adults

Elderberry for Immune Support

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)

Altitude Sickness Prevention and Efficacy of Comparative Treatments

Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude

Airway IgA: Respiratory Tract IgA Levels in Critically Ill Intubated Patients

A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing

A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

Post-extubation Assessment of Laryngeal Symptoms and Severity

A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program

TDAP in Burn Patients (Group 2)

Adapting the Tumor Board Model for Mental Illness and Cancer

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema

Indirect Calorimetry Usage and Effect in Ventilator-free Days and Muscle Thickness in Septic Ventilated Patients

Goals of Care Conversations Study

Feasibility of a Music Therapy Intervention to Decrease Stress During Pediatric Critical Care

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19